With the analysis among 1,468 patents, we discovered top 216 key players by total patent application. Celgene Corp., Amgen, Inc., Novartis AG are dominant in this area. They take 28.27% of the total patent filing.
New Jersey, United States
Patent: 165
California, United States
Patent: 141
Basel-Stadt, Switzerland
Patent: 109
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 70
California, United States
Patent: 43
California, United States
Patent: 39
California, United States
Patent: 29
Massachusetts, United States
Patent: 28
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 25
With the analysis among 26 patents, we discovered top 10 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, ALX Oncology, Inc., Oncoheroes Biosciences Inc are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 5
Oncoheroes Biosciences Inc
Massachusetts, United States
Patent: 3
Sumitomo Dainippon Pharma Oncology, Inc.
Starton Therapeutics, Inc.
New York, United States
Patent: 2
Regenacy Pharmaceuticals LLC
Massachusetts, United States
Patent: 2
Massachusetts, United States
Patent: 1
Noord-Holland, Netherlands
Patent: 1
California, United States
Patent: 1
With the analysis among related 382 patents applied in the last 5 years. We discover 105 most active companies in this area. The fast-growing MacroGenics, Inc., Celgene Corp., Geron Corp. take 21.99% of patent filing during this period.
New Jersey, United States
Patent: 27
California, United States
Patent: 20
Basel-Stadt, Switzerland
Patent: 18
Nottingham Trent University
NOTTINGHAM, United Kingdom
Patent: 17
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Silence Therapeutics GmbH
Berlin, Germany
Patent: 14
Bern, Switzerland
Patent: 12
University Health Network
Ontario, Canada
Patent: 11
Ohara Pharmaceutical Co., Ltd.
Shiga-ken, Japan
Patent: 10
With the analysis among related 382 patents in last 5 years, we discover 56 new entrants. Nottingham Trent University, Silence Therapeutics GmbH, NanoString Technologies, Inc. are the most active new entrants in this area.
Nottingham Trent University
NOTTINGHAM, United Kingdom
Patent: 17
Silence Therapeutics GmbH
Berlin, Germany
Patent: 14
NanoString Technologies, Inc.
Washington, United States
Patent: 9
Washington, United States
Patent: 8
Otsuka Pharmaceutical Co., Ltd.
undefined undefined
Patent: 7
Actinium Pharmaceuticals, Inc.
New York, United States
Patent: 7
California, United States
Patent: 5
California, United States
Patent: 4
With the analysis among 330 patents, we discovered top 47 universities and scientific research institutions by total patent application. Nottingham Trent University, University of Bern, Friedrich-Alexander-Universität Erlangen-Nürnberg are dominant in this area. They take 21.52% of the total patent filing.
Nottingham Trent University
NOTTINGHAM, United Kingdom
Patent: 17
Bern, Switzerland
Patent: 13
Friedrich-Alexander-Universität Erlangen-Nürnberg
Bayern, Germany
Patent: 11
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 9
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 7
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 6
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 6
The Johns Hopkins University